SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891293-16-000197
Filing Date
2016-11-08
Accepted
2016-11-08 16:50:27
Documents
42
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cti10q09302016.htm 10-Q 909319
2 EXHIBIT 31.1 ex311-cti10q09302016.htm EX-31.1 11021
3 EXHIBIT 31.2 ex312-cti10q09302016.htm EX-31.2 12153
4 EXHIBIT 32 ex32-cti10q09302016.htm EX-32 11941
  Complete submission text file 0000891293-16-000197.txt   3097997

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ctic-20160930.xml EX-101.INS 389089
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20160930.xsd EX-101.SCH 22445
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20160930_cal.xml EX-101.CAL 61531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20160930_def.xml EX-101.DEF 105383
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20160930_lab.xml EX-101.LAB 342927
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20160930_pre.xml EX-101.PRE 186193
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 161981835
SIC: 2834 Pharmaceutical Preparations